Azenta, Inc. (AZTA) – What Are Researchers Saying About This Stock?

Shares of Azenta, Inc. (NASDAQ:AZTA) have earned a consensus rating of “Hold” from the seven research firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $41.20.

AZTA has been the topic of a number of recent analyst reports. Wall Street Zen downgraded shares of Azenta from a “buy” rating to a “hold” rating in a research note on Sunday, October 18th. Needham & Company LLC restated a “buy” rating and issued a $37.00 price objective on shares of Azenta in a research note on Monday, September 14th. Finally, Weiss Ratings raised shares of Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 26th.

Azenta Stock Performance

Shares of AZTA opened at $39.16 on Friday. Azenta has a 52 week low of $15.93 and a 52 week high of $46.41. The firm has a market cap of $1.72 billion, a P/E ratio of -14.19 and a beta of 1.47. The firm’s 50-day simple moving average is $35.32 and its 200 day simple moving average is $28.47.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. Azenta had a positive return on equity of 1.18% and a negative net margin of 20.63%. The business had revenue of $161.18 million during the quarter, compared to analysts’ expectations of $149.31 million.

Hedge Funds Weigh In On Azenta

Hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in Azenta in the second quarter valued at $192,152,000. Allspring Global Investments Holdings LLC boosted its holdings in Azenta by 16.3% in the first quarter. Allspring Global Investments Holdings LLC now owns 1,613,914 shares of the company’s stock valued at $34,183,000 after purchasing an additional 225,867 shares during the period. Front Street Capital Management Inc. purchased a new stake in shares of Azenta during the 2nd quarter worth approximately $33,212,000. American Capital Management Inc. raised its position in shares of Azenta by 26.9% in the 1st quarter. American Capital Management Inc. now owns 1,296,024 shares of the company’s stock valued at $27,385,000 after purchasing an additional 274,588 shares in the last quarter. Finally, Bank of America Corp DE acquired a new stake in Azenta during the 2nd quarter valued at $17,058,000. Institutional investors and hedge funds own 99.08% of the company’s stock.

Azenta Company Profile

Azenta, Inc is a life sciences company that provides products and services for the management, storage, and analysis of biological and chemical samples. Its offerings support pharmaceutical, biotechnology, academic, and clinical research organizations throughout the sample lifecycle, from collection and processing to long-term storage and retrieval.

The company’s portfolio includes automated and ultra-low-temperature sample storage systems, laboratory automation equipment, consumables, and software for sample tracking and management.